- Home
- ADAP vs PLCE Comparison
ADAP vs PLCE Comparison
Compare ADAP & PLCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADAP
- PLCE
- Stock Information
- Founded
- ADAP 2008
- PLCE 1969
- Country
- ADAP United Kingdom
- PLCE United States
- Employees
- ADAP N/A
- PLCE N/A
- Industry
- ADAP Biotechnology: Pharmaceutical Preparations
- PLCE Clothing/Shoe/Accessory Stores
- Sector
- ADAP Health Care
- PLCE Consumer Discretionary
- Exchange
- ADAP Nasdaq
- PLCE Nasdaq
- Market Cap
- ADAP 75.5M
- PLCE 128.9M
- IPO Year
- ADAP 2015
- PLCE 1997
- Fundamental
- Price
- ADAP $0.27
- PLCE $5.00
- Analyst Decision
- ADAP Buy
- PLCE Hold
- Analyst Count
- ADAP 6
- PLCE 1
- Target Price
- ADAP $1.35
- PLCE $6.00
- AVG Volume (30 Days)
- ADAP 644.7K
- PLCE 782.5K
- Earning Date
- ADAP 08-11-2025
- PLCE 06-06-2025
- Dividend Yield
- ADAP N/A
- PLCE N/A
- EPS Growth
- ADAP N/A
- PLCE N/A
- EPS
- ADAP N/A
- PLCE N/A
- Revenue
- ADAP $179,639,000.00
- PLCE $1,360,516,000.00
- Revenue This Year
- ADAP N/A
- PLCE N/A
- Revenue Next Year
- ADAP $35.48
- PLCE $1.47
- P/E Ratio
- ADAP N/A
- PLCE N/A
- Revenue Growth
- ADAP 878.53
- PLCE N/A
- 52 Week Low
- ADAP $0.20
- PLCE $3.66
- 52 Week High
- ADAP $1.48
- PLCE $19.74
- Technical
- Relative Strength Index (RSI)
- ADAP 56.59
- PLCE 56.41
- Support Level
- ADAP $0.23
- PLCE $4.85
- Resistance Level
- ADAP $0.28
- PLCE $4.72
- Average True Range (ATR)
- ADAP 0.02
- PLCE 0.29
- MACD
- ADAP 0.00
- PLCE 0.18
- Stochastic Oscillator
- ADAP 87.96
- PLCE 97.13
About ADAP Adaptimmune Therapeutics plc
Adaptimmune Therapeutics PLC is a commercial-stage biopharmaceutical company working to redefine the treatment of solid tumor cancers with cell therapies. It has developed a comprehensive proprietary platform that enables it to identify cancer targets, find and genetically engineer T-cell receptors, and produce TCR therapeutic candidates for administration to patients. Its programs include MAGE-A4 SPEAR T-cell therapy, NY-ESO SPEAR T-cell, CD70, and others for multiple cancer types.
About PLCE Children's Place Inc. (The)
Children's Place Inc operate an omni-channel children's specialty portfolio of brands in North America. It designs, contract to manufacture, and sell fashionable, high-quality apparel, accessories and footwear predominantly at value prices under proprietary The Children's Place, Place, Baby Place, Gymboree, Sugar & Jade, and PJ Place brand names. The Company classifies its business into two segments: The Children's Place U.S. and The Children's Place International.